Q2 2025 · 13F-HR
Alphabet Inc. (GOOG, GOOGL)holdings as filed
Filed 2025-08-01 · accession 0001652044-25-000063
$2.14B
Reported value
36
Positions
2025-06-30
Period end
The Brief · Alphabet Inc. (GOOG, GOOGL) · Q2 2025
AI · grounded in 13F
Alphabet Inc. (GOOG, GOOGL) established a new position in ASTS valued at $417.9M. The fund also initiated new stakes in ARM for $317.1M and FRSH for $241.6M. Additional new positions include PL at $194.9M and RVMD at $152.1M. Total assets under management stand at $2.1B across 36 positions.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00217D100 | ASTS | AST SPACEMOBILE INC | $417.9M | 19.6% | 8,943,486 | Common | SHARED |
| 042068205 | ARM | ARM HOLDINGS PLC | $317.1M | 14.9% | 1,960,784 | Common | SHARED |
| 358054104 | FRSH | FRESHWORKS INC | $241.6M | 11.3% | 16,206,643 | Common | SHARED |
| 72703X106 | PL | PLANET LABS PBC | $194.9M | 9.13% | 31,942,641 | Common | SHARED |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $152.1M | 7.12% | 4,133,277 | Common | SHARED |
| 59267L107 | — | METSERA INC | $141.2M | 6.61% | 4,961,744 | Common | SHARED |
| 92539P101 | — | VERVE THERAPEUTICS INC | $136.7M | 6.40% | 12,168,489 | Common | SHARED |
| 37637K108 | GTLB | GITLAB INC | $122.9M | 5.76% | 2,724,712 | Common | SHARED |
| 88023B103 | TEM | TEMPUS AI INC | $98.6M | 4.62% | 1,551,102 | Common | SHARED |
| 252131107 | DXCM | DEXCOM INC | $90.5M | 4.24% | 1,036,937 | Common | SHARED |
| 90364P105 | PATH | UIPATH INC | $90.0M | 4.22% | 7,034,337 | Common | SHARED |
| 74168J101 | PRME | PRIME MEDICINE INC | $37.2M | 1.74% | 15,062,498 | Common | SHARED |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $29.6M | 1.39% | 2,412,471 | Common | SHARED |
| 687793109 | OSCR | OSCAR HEALTH INC | $10.3M | 0.48% | 481,988 | Common | SHARED |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $7.7M | 0.36% | 2,812,500 | Common | SHARED |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $6.6M | 0.31% | 1,464,015 | Common | SHARED |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $5.7M | 0.27% | 241,264 | Common | SHARED |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $5.5M | 0.26% | 321,604 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $5.4M | 0.25% | 1,568,753 | Common | SHARED |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $3.9M | 0.18% | 208,697 | Common | SHARED |
| 55083R203 | LYEL | LYELL IMMUNOPHARMA INC | $2.6M | 0.12% | 293,256 | Common | SHARED |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $2.6M | 0.12% | 889,979 | Common | SHARED |
| 344174107 | FHTX | FOGHORN THERAPEUTICS INC | $2.4M | 0.11% | 500,901 | Common | SHARED |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $2.1M | 0.10% | 22,711 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $1.6M | 0.07% | 698,262 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $1.6M | 0.07% | 1,077,080 | Common | SHARED |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $1.5M | 0.07% | 640,882 | Common | SHARED |
| 91864C107 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $1.4M | 0.07% | 1,513,644 | Common | SHARED |
| 30063P105 | EXK | EXACT SCIENCES CORP | $1.2M | 0.06% | 23,205 | Common | SHARED |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $1.1M | 0.05% | 662,584 | Common | SHARED |
| 44916K106 | HYPR | HYPERFINE INC | $647,078 | 0.03% | 898,720 | Common | SHARED |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $558,580 | 0.03% | 915,705 | Common | SHARED |
| 22053A107 | QNCX | QUINCE THERAPEUTICS INC | $312,051 | 0.01% | 189,122 | Common | SHARED |
| 014442107 | ALEC | ALECTOR INC | $246,212 | 0.01% | 175,866 | Common | SHARED |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $98,123 | 0.00% | 14,262 | Common | SHARED |
| 759916109 | RGEN | REPLIGEN CORP | $47,638 | 0.00% | 383 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.